These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 31968252

  • 1. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
    Liu Y, Yin N, Wang X, Khoor A, Sambandam V, Ghosh AB, Fields ZA, Murray NR, Justilien V, Fields AP.
    Cell Rep; 2020 Jan 21; 30(3):771-782.e6. PubMed ID: 31968252
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
    Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR, Fields AP.
    Cancer Cell; 2014 Feb 10; 25(2):139-51. PubMed ID: 24525231
    [Abstract] [Full Text] [Related]

  • 4. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
    Fields AP, Justilien V, Murray NR.
    Adv Biol Regul; 2016 Jan 10; 60():47-63. PubMed ID: 26754874
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.
    Justilien V, Jameison L, Der CJ, Rossman KL, Fields AP.
    J Biol Chem; 2011 Mar 11; 286(10):8149-8157. PubMed ID: 21189248
    [Abstract] [Full Text] [Related]

  • 9. The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.
    Qian J, Hassanein M, Hoeksema MD, Harris BK, Zou Y, Chen H, Lu P, Eisenberg R, Wang J, Espinosa A, Ji X, Harris FT, Rahman SM, Massion PP.
    Proc Natl Acad Sci U S A; 2015 Mar 17; 112(11):3469-74. PubMed ID: 25733852
    [Abstract] [Full Text] [Related]

  • 10. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
    Wang Y, Justilien V, Brennan KI, Jamieson L, Murray NR, Fields AP.
    Oncogene; 2017 Jan 26; 36(4):534-545. PubMed ID: 27321186
    [Abstract] [Full Text] [Related]

  • 11. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
    Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembelé D, Martinet N, Thibault C, Huelsken J, Brambilla E, du Manoir S.
    PLoS One; 2010 Jan 29; 5(1):e8960. PubMed ID: 20126410
    [Abstract] [Full Text] [Related]

  • 12. SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.
    Ferone G, Song JY, Sutherland KD, Bhaskaran R, Monkhorst K, Lambooij JP, Proost N, Gargiulo G, Berns A.
    Cancer Cell; 2016 Oct 10; 30(4):519-532. PubMed ID: 27728803
    [Abstract] [Full Text] [Related]

  • 13. SOX2 Determines Lineage Restriction: Modeling Lung Squamous Cell Carcinoma in the Mouse.
    Murray NR, Justilien V, Fields AP.
    Cancer Cell; 2016 Oct 10; 30(4):505-507. PubMed ID: 27728797
    [Abstract] [Full Text] [Related]

  • 14. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
    Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Ribeiro U, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M.
    Nat Genet; 2009 Nov 10; 41(11):1238-42. PubMed ID: 19801978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
    Regala RP, Davis RK, Kunz A, Khoor A, Leitges M, Fields AP.
    Cancer Res; 2009 Oct 01; 69(19):7603-11. PubMed ID: 19738040
    [Abstract] [Full Text] [Related]

  • 18. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y, Yasui K, Zen Y, Zen K, Dohi O, Endo M, Tsuji K, Wakabayashi N, Itoh Y, Naito Y, Taniwaki M, Nakanuma Y, Okanoue T, Yoshikawa T.
    Cancer Genet Cytogenet; 2010 Oct 15; 202(2):82-93. PubMed ID: 20875870
    [Abstract] [Full Text] [Related]

  • 19. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F, Adisurya H, Wemmert S, Lerner C, Greiner M, Zimmermann R, Hasenfus A, Wagner M, Smola S, Pfuhl T, Bozzato A, Al Kadah B, Schick B, Linxweiler M.
    Oncotarget; 2017 Jan 17; 8(3):4922-4934. PubMed ID: 28002801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.